Drug Type AAV based gene therapy |
Synonyms PRCN-226 |
Target |
Mechanism DRDs agonists(Dopamine receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinsonian Disorders | Discovery | US | - |